February 01, 2008 Archives - Renal and Urology News

Print Issue: February 01, 2008

For Semen Collection, Privacy Please

WASHINGTON, D.C.—A recent survey identified what men would like in a semen collection room at an assisted reproduction clinic. They want sound privacy, cleanliness, and face-to-face instruction.

Patricia Muñoz, MD

High BK Virus Infection Rate Found

CHICAGO—Spanish researchers say they have found a high rate of BK virus (BKV) viremia during the first six months after renal transplantation, but after that the rate declines significantly.

Stan Honig, MD

ED Is a Predictor of Cardiac Disease: A Urologic Perspective

Erectile dysfuction (ED), defined as the inability to reach or maintain an erection sufficient for satisfactory sexual performance, is age-related and an extremely prevalent medical condition. It is estimated to affect more than half of all men over the age of 60, and in the United States alone, ED will develop in more than 600,000 men aged 40-69 annually.1

Manufacturing Issue Delays Restart of CIS Drug

Indevus Pharmaceuticals, Inc., of Lexington, Mass., has received a non-approvable letter from the FDA for Valstar (valrubicin solution), the only approved product for therapy of bacillus Calmette-Guérin-refractory carcinoma in situ of the urinary bladder.

New Dosage for Glycemic Control in Type 2 Diabetes

Depomed, Inc., of Menlo Park, Calif., has received approval for 1,000-mg strength tablets of Glumetza (metformin hydrochloride extended-release tablets), which is indicated alone or in combination with a sulfonylurea or insulin as an adjunctive therapy to improve glycemic control in adult type 2 diabetes patients.

Next post in FDA News